He D - Search Results

1

In vitro evaluation of the safety and efficacy of a high-power 450-nm semiconductor blue laser in the treatment of benign prostate hyperplasia.

Xu X, Jiang D, Liu G, Mu L, Zeng J, Yang L, He D. Xu X, et al. Among authors: he d. Lasers Med Sci. 2022 Feb;37(1):555-561. doi: 10.1007/s10103-021-03297-y. Epub 2021 Mar 26. Lasers Med Sci. 2022. PMID: 33770281

2

[Etiology and treatment of bladder spasm associated with benign prostatic hyperplasia].

Zhao J, He DL, Liu RM, Wang MZ, Wang XN, Xing JP, Nan XY. Zhao J, et al. Zhonghua Nan Ke Xue. 2005 Apr;11(4):275-7. Zhonghua Nan Ke Xue. 2005. PMID: 15921258 Chinese.

3

[Clinical evaluation of BTAstat, NMP22, HA, survivin, CD44v6, vEGF and VUC in bladder cancer diagnosis].

Sun Y, He H, Ma Q, Wang XY, Yang L, He DL. Sun Y, et al. Zhonghua Yi Xue Za Zhi. 2005 Sep 14;85(35):2507-12. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16321281 Chinese.

4

Comparison of seven screening methods in the diagnosis of bladder cancer.

Sun Y, He DL, Ma Q, Wan XY, Zhu GD, Li L, Luo Y, He H, Yang L. Sun Y, et al. Chin Med J (Engl). 2006 Nov 5;119(21):1763-71. Chin Med J (Engl). 2006. PMID: 17097029

5

[Identification of gene expression patterns in superficial and invasive human bladder cancers].

Zhou L, Shi BT, Wang SX, Luo Y, Yang L, Zhang LL, Wang XY, He DL. Zhou L, et al. Zhonghua Yi Xue Za Zhi. 2007 Mar 27;87(12):798-801. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17565857 Chinese.

6

Effect of long-term partial bladder outlet obstruction on caldesmon isoforms and their correlation with contractile function.

Yang L, He DL, Wang S, Cheng HP, Wang XY. Yang L, et al. Acta Pharmacol Sin. 2008 May;29(5):600-5. doi: 10.1111/j.1745-7254.2008.00784.x. Acta Pharmacol Sin. 2008. PMID: 18430369

7

Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma.

Li L, Gao Y, Zhang L, Zeng J, He D, Sun Y. Li L, et al. Among authors: he d. Cancer Lett. 2008 Dec 8;272(1):61-9. doi: 10.1016/j.canlet.2008.06.033. Epub 2008 Aug 23. Cancer Lett. 2008. PMID: 18723275

8

[Expression of Smad4 in prostate cancer LNCaP and ARCaP cell lines with different metastatic potentials and its significance].

Wu KJ, Zhang D, Zhu GF, Cheng HP, Zeng J, Zhang LL, Wang XY, He DL. Wu KJ, et al. Among authors: he dl. Zhonghua Nan Ke Xue. 2009 Jan;15(1):41-4. Zhonghua Nan Ke Xue. 2009. PMID: 19288748 Chinese.

9

Shock wave induced kidney injury promotes calcium oxalate deposition.

Xue YQ, He DL, Chen XF, Li X, Zeng J, Wang XY. Xue YQ, et al. J Urol. 2009 Aug;182(2):762-5. doi: 10.1016/j.juro.2009.03.080. Epub 2009 Jun 18. J Urol. 2009. PMID: 19539311

10

Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.

Wu KJ, Zeng J, Zhu GD, Zhang LL, Zhang D, Li L, Fan JH, Wang XY, He DL. Wu KJ, et al. Among authors: he dl. Acta Pharmacol Sin. 2009 Aug;30(8):1162-8. doi: 10.1038/aps.2009.94. Epub 2009 Jul 6. Acta Pharmacol Sin. 2009. PMID: 19578386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,984 results

Search Page

Filters